Commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity'

Scritto il 02/03/2026
da Yuxin Liang

No abstract

Eur J Heart Fail. 2026 Jan 23:xuaf022. doi: 10.1093/ejhf/xuaf022. Online ahead of print.

NO ABSTRACT

PMID:41771083 | DOI:10.1093/ejhf/xuaf022